Приказ основних података о документу
Correlation analysis confirms differences in antioxidant defence in the blood of types I and II schizophrenic male patients treated with anti-psychotic medication
dc.creator | Miljević, Cedo D | |
dc.creator | Nikolić-Kokić, Aleksandra | |
dc.creator | Saičić, Zorica | |
dc.creator | Milosavljević, Maja | |
dc.creator | Blagojević, Duško | |
dc.creator | Lecić-Tosevski, Dusica M | |
dc.creator | Jones, David R | |
dc.creator | Spasić, Mihajlo | |
dc.date.accessioned | 2017-11-23T11:10:53Z | |
dc.date.available | 2015-11-17T10:26:51Z | |
dc.date.issued | 2010 | sr |
dc.identifier.issn | 0165-1781 | sr |
dc.identifier.other | Rad_konverzija_3360 | sr |
dc.identifier.uri | https://radar.ibiss.bg.ac.rs/handle/123456789/1365 | |
dc.description.abstract | The activities of antioxidant defence enzymes were determined in erythrocytes isolated from types I and II schizophrenic male patients and from healthy controls. Significant differences in superoxide dismutase (SOD) activity (type I: 3284 +/- 577; type II: 2959 +/- 697 compared with controls: 3778 +/- 577; analysis of variance (ANOVA) P<0.001), catalase (CAT) activity (type I: 17.8 +/- 1.8 compared to type II: 19.2 +/- 1.5 and both compared with controls: 19.2 +/- 1.5; ANOVA P<0.05). glutathione peroxidase (GSH-Px) activity (controls: 17.8 +/- 2.3; type I: 13.9 +/- 2.9 and type II: 11.6 +/- 1.9; ANOVA P<0.001) as well as in glutathione reductase (GR) activity (controls: 5.0 +/- 0.8; type I: 4.3 +/- 0.9 and type II: 4.5 +/- 0.8; ANOVA P<0.01) were apparent. Correlation analysis of antioxidant defence enzymes showed significant negative correlation between GSH-Px and CAT activities (P<0.01) in type I patients. In type II patients, GSH-Px activity was significantly positively correlated with GR (P<0.01). Canonical discriminant analysis separated type I and type II patients from controls (and among each other) with a high degree of certainty according to the overall group composition of antioxidant defence enzymes. Our results indicate differences in the composition of antioxidant defence between controls and antipsychotic treated type I and type II patients with a possible negative feedback influence on the pathological process, which could provide a rationale for applying antioxidants during schizophrenic therapy. (C) 2009 Elsevier Ireland Ltd. All rights reserved. | en |
dc.description.sponsorship | Ministry of Science Republic of Serbia [1430348, 143035B] | sr |
dc.language.iso | English | sr |
dc.rights | restrictedAccess | |
dc.source | Psychiatry Research | sr |
dc.title | Correlation analysis confirms differences in antioxidant defence in the blood of types I and II schizophrenic male patients treated with anti-psychotic medication | en |
dc.type | article | |
dc.rights.license | ARR | |
dcterms.abstract | Миљевић, Цедо Д; Саичић, Зорица; Спасић, Михајло Б.; Благојевић, Душко П.; Јонес, Давид Р; Лецић-Тосевски, Дусица М; Николић-Кокић, Aлександра; Милосављевић, Маја; | |
dc.citation.issue | 1 | sr |
dc.citation.volume | 178 | sr |
dc.citation.epage | 72 | sr |
dc.type.version | publishedVersion | en |
dc.citation.rank | M21 | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_ibiss_1365 |
Документи
Датотеке | Величина | Формат | Преглед |
---|---|---|---|
Уз овај запис нема датотека. |